← 產業報告目錄
Postbiotics Supplements Market Size, Share & Trends Analysis Report By Type (Bacteria, Yeast), By Form (Soft gels, Capsules/Tablets, Powder/ Granules, Gummies, Others), By Application (Personal Care and Cosmetics, Food and Beverages, Animal Feed, Pharmaceuticals, Others), By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Other出版日期 2026-01-01頁數 180報告編號 INSIGHTACE-4d4f1c8aa0
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Postbiotics Supplements Market on a global scale was estimated at USD 12.8 Bn in 2024 and is set to attain USD 36.3 Bn by 2034, with a projected CAGR of 11.0% between 2025 and 2034.
The Postbiotics Supplements sector involves bioactive compounds produced when probiotics ferment prebiotics; they have the potential to improve the health and productivity of animals. This domain has witnessed meaningful transformation owing to technological breakthroughs and shifting industrial dynamics.
Market momentum is supported by expanding appetite for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, supported by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Postbiotics Supplements Market Snapshot
Chapter 4. Global Postbiotics Supplements Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type Estimates & Trend Analysis
5.1. by Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Type:
5.2.1. Bacteria
5.2.2. Yeast
Chapter 6. Market Segmentation 2: by Form Estimates & Trend Analysis
6.1. by Form & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Form:
6.2.1. Soft gels
6.2.2. Capsules/Tablets
6.2.3. Powder/ Granules
6.2.4. Gummies
6.2.5. Others
Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis
7.1. by Application & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:
7.2.1. Personal Care
7.2.2. Cosmetics
7.2.3. Food and Beverages
7.2.4. Animal Feed
7.2.5. Pharmaceuticals
7.2.6. Others
Chapter 8. Postbiotics Supplements Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Postbiotics Supplements Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
8.1.2. North America Postbiotics Supplements Market Revenue (US$ Million) Estimates and Forecasts by Form, 2021-2034
8.1.3. North America Postbiotics Supplements Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.1.4. North America Postbiotics Supplements Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Postbiotics Supplements Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
8.2.2. Europe Postbiotics Supplements Market Revenue (US$ Million) Estimates and Forecasts by Form, 2021-2034
8.2.3. Europe Postbiotics Supplements Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.2.4. Europe Postbiotics Supplements Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Postbiotics Supplements Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
8.3.2. Asia Pacific Postbiotics Supplements Market Revenue (US$ Million) Estimates and Forecasts by Form, 2021-2034
8.3.3. Asia-Pacific Postbiotics Supplements Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.3.4. Asia Pacific Postbiotics Supplements Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Postbiotics Supplements Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
8.4.2. Latin America Postbiotics Supplements Market Revenue (US$ Million) Estimates and Forecasts by Form, 2021-2034
8.4.3. Latin America Postbiotics Supplements Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.4.4. Latin America Postbiotics Supplements Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Postbiotics Supplements Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
8.5.2. Middle East & Africa Postbiotics Supplements Market Revenue (US$ Million) Estimates and Forecasts by Form, 2021-2034
8.5.3. Middle East & Africa Postbiotics Supplements Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.5.4. Middle East & Africa Postbiotics Supplements Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Novachem Srl
9.2.2. Cargill
9.2.3. Probulin
9.2.4. Korea Biopharm
9.2.5. Archer-Daniels Midland
9.2.6. Sabinsa Corporation
9.2.7. Postbiotica Srl
9.2.8. Lactobio A/S
9.2.9. MCLS
9.2.10. AB-Biotics S.A
9.2.11. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們